ROYAL BANK OF CANADA - CASCADIAN THERAPEUTICS INC ownership

CASCADIAN THERAPEUTICS INC's ticker is CASC and the CUSIP is 14740B606. A total of 1 filers reported holding CASCADIAN THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of CASCADIAN THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$2,000
-88.2%
732
-82.1%
0.00%
Q3 2017$17,000
+466.7%
4,087
+270.2%
0.00%
Q2 2017$3,000
-25.0%
1,104
+9.3%
0.00%
Q1 2017$4,0000.0%1,010
+0.4%
0.00%
Q4 2016$4,0001,0060.00%
Other shareholders
CASCADIAN THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 3,000,000$12,420,0003.14%
Abingworth LLP 925,000$3,830,0002.85%
BVF INC/IL 3,133,224$12,972,0002.21%
NEA Management Company, LLC 9,064,575$37,527,0001.30%
Anson Funds Management LP 670,929$2,778,0001.15%
Sandia Holdings, LLC 543,719$2,251,0001.13%
Redmile Group, LLC 4,072,424$16,860,0001.09%
Avoro Capital Advisors LLC 1,821,248$7,540,0000.96%
FT Options LLC 143,429$594,0000.78%
DAFNA Capital Management LLC 185,259$767,0000.65%
View complete list of CASCADIAN THERAPEUTICS INC shareholders